title: [More accurate diagnosis could identify patients suitable for tacrine therapy].
authors.forename: N
authors.initials: N
authors.lastname: Andreasen
authors.forename: S
authors.initials: S
authors.lastname: Eriksson
authors.forename: I
authors.initials: I
authors.lastname: Karlsson
authors.forename: B
authors.initials: B
authors.lastname: Lindahl
authors.forename: M
authors.initials: M
authors.lastname: Lund
authors.forename: A
authors.initials: A
authors.lastname: Nordberg
authors.forename: A
authors.initials: A
authors.lastname: Wimo
authors.forename: B
authors.initials: B
authors.lastname: Winblad
authors.forename: R
authors.initials: R
authors.lastname: Astrand
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D013619:Tacrine / Q000627:therapeutic use*
chemical_list: D002800:Cholinesterase Inhibitors; D013619:Tacrine
vernacular_title: Skärpt diagnostik kan identifiera lämpliga takrinpatienter.